{"nct_id":"NCT03895684","title":"Phase 1 Trial of the LSD1 Inhibitor SP-2577 (Seclidemstat) in Patients With Advanced Solid Tumors","status":"COMPLETED","status_verified_date":"2021-10","start_date":"2019-06-25","start_date_type":"ACTUAL","primary_completion_date":"2021-04-13","primary_completion_date_type":"ACTUAL","completion_date":"2021-04-13","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["SLRX"]}